Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: The Biomarker Toolkit — an evidence-based guideline to predict cancer biomarker success and guide development

Fig. 2

Successful and stalled biomarker clinical utility studies. Stacked bar chart showing AV, analytical validity; CE, cost-effectiveness; CUs, clinical usefulness; FEAS, feasibility; HF, human factor; IMPL, implementation; and DA, decisional analysis studies in successful A) BC, B) CRC biomarkers and stalled C) BC and D) CRC biomarkers. BC, breast cancer, CRC, colorectal cancer

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us